Welcome to the fabulous world of microorganisms that are beneficial to our health !
Bifidobacterium animalis spp lactis Bifidobacterium animalis spp lactis BS01 is a bifidobacterium belonging to the phylum, i.e. group, of Actinobacteria.
Bifidobacterium animalis spp lactis is the bacterium most frequently found in fermented dairy products. Isolated in 1997, this bifidobacterium is classified as a Gram-positive bacteria. Furthermore, this bacterium has the ability to grow in the complete absence of oxygen.
Bifidobacterium animalis spp lactis has an anti-inflammatory activity. Indeed, the consumption and fermentation of lactose, a source of energy, is the "guilty pleasure" of this bacterium. The latter then produces short-chain fatty acids (SCFAs), including butyrate and propionate. These molecules are used as a source of energy by our colon cells. This production of SCFAs, combined with the acidification caused by the development of Bifidobacterium animalis spp lactis, has the beneficial effect of creating an unfavourable environment for the development of Enterobacteriaceae, Gram-negative bacteria usually responsible for infectious colitis.
In conclusion, Bifidobacterium animalis spp lactis promotes the development of immune cells. It also has a beneficial effect on food and respiratory allergies and associated intestinal and pulmonary manifestations.
Bifidobacterium animalis spp lactis is a bacterium of the Actinobacteria phylum. It produces short-chain fatty acids that are beneficial to colonic cells. Its development creates an unfavourable environment for the proliferation of certain pathogenic bacteria.
The particularities of THERASCIENCE laboratory
In order to protect the strains during their passage through the various parts of the digestive tract, but also to guarantee their protection against oxidation, humidity, as well as any interaction with other components, the THERASCIENCE Laboratory carries out an individual microencapsulation of the various strains of microbiota thanks to various patented processes: PROBIO-PROTECT® et SUVIMINE PROTECT®
Pour en savoir plus cliquez sur PROBIO-PROTECT® et SUVIMINE PROTECT® .
Bifidobacterium animalis lactis is the subject of more than 573 scientific publications.
- Chen S, Jiang PP, Yu D, Liao GC, Wu SL, Fang AP, Chen PY, Wang XY, Luo Y, Long JA, Zhong RH, Liu ZY, Li CL, Zhang DM, Zhu HL. "Effects of probiotic supplementation on serum trimethylamine-N-oxide level and gut microbiota composition in young males: a double-blinded randomized controlled trial." Eur J Nutr. 2021 Mar;60(2):747-758. Epub (2020). PMID: 32440731.
- Merenstein, Daniel et al. “Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome.” Nutrients vol. 13,8 2814. (2021).
- Ba, Zhaoyong et al. “Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp. lactis BB-12 on Fecal Microbiota, Gut Transit Time, and Short-Chain Fatty Acids in Healthy Young Adults.” mSphere vol. 6,4 (2021)